From GlobeNewswire: 2025-06-09 22:52:00

Anteris Technologies Global Corp. appointed David Roberts and Gregory Moss to its Board of Directors, with Dr. Wenyi Gu resigning. Roberts is President of LeMaitre Vascular, Inc., while Moss is Chief Business and Legal Officer at Evommune, Inc. Both will help guide Anteris through its next phase of growth, including the upcoming global pivotal PARADIGM study for the DurAVR® THV. Anteris is a global structural heart company focused on designing, developing, and commercializing medical devices to restore healthy heart function, with its lead product being the DurAVR® Transcatheter Heart Valve. The valve is designed to treat aortic stenosis, using ADAPT® tissue technology.



Read more at GlobeNewswire: Anteris Appoints David Roberts and Gregory Moss to its